Moderna COVID-19 Vaccine Is 94.5% Effective, Company Reports

Moderna COVID-19 Vaccine Is 94.5% Effective, Company Reports.
The company released the data, which was
confirmed by members of the Data Safety
and Monitoring Board, on Monday.
It was one of the greatest moments in my life and my career, Dr. Tal Zacks, Moderna's chief medical officer, via statement.
It is absolutely amazing to be able to develop this vaccine and see the ability to prevent symptomatic disease with such high efficacy, Dr. Tal Zacks, Moderna's chief medical officer, statement.
Moderna's vaccine is the second in
the U.S. to have a high success rate.
Pfizer announced last week that its vaccine
is over 90% effective against the virus.
One advantage Moderna's vaccine has over Pfizer's
is that it can be kept at minus 20 degrees Celsius rather than minus 75 degrees Celsius.
It can also last 30 days in the refrigerator,
whereas Pfizer's vaccine can only last five days.
Dr. Anthony Fauci expects the first coronavirus vaccinations to begin "towards the latter part of December, rather than the early part of December."